(Q35623318)

9 August 2017

1 reference

title

Strategies for the development of PSA-based vaccines for the treatment of advanced prostate cancer (English)

1 reference

9 August 2017

1 reference

4

Jeffrey Schlom

1 reference

9 August 2017

2

James L Gulley

1 reference

9 August 2017

Philip M Arlen

1

1 reference

9 August 2017

Kwong-Yok Tsang

series ordinal

3

1 reference

9 August 2017

publication date

1 August 2003

1 reference

Expert Review of Vaccines

9 August 2017

published in

1 reference

9 August 2017

volume

2

1 reference

9 August 2017

issue

4

1 reference

9 August 2017

page(s)

483-493

1 reference

Induction of human cytotoxic T lymphocytes specific for prostate-specific antigen

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.4.483

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.4.483

Generation of Human Cytotoxic T Cells Specific for Human Carcinoembryonic Antigen Epitopes From Patients Immunized With Recombinant Vaccinia-CEA Vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.4.483

The use of a rapid ELISPOT assay to analyze peptide-specific immune responses in carcinoma patients to peptide vs. recombinant poxvirus vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.4.483

Immunotherapy of cancer with dendritic-cell-based vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.4.483

Bone marrow-generated dendritic cells pulsed with tumor extracts or tumor RNA induce antitumor immunity against central nervous system tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.4.483

Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.4.483

Specific immunotherapy using a recombinant vaccinia virus expressing human carcinoembryonic antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.4.483

Diversified prime and boost protocols using recombinant vaccinia virus and recombinant non-replicating avian pox virus to enhance T-cell immunity and antitumor responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.4.483

Adhesion receptors of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.4.483

On the role of costimulation in tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.4.483

Tumor immunology: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.4.483

Costimulation of T cells for tumor immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.4.483

21 January 2018

Identifiers

DOI

10.1586/14760584.2.4.483

1 reference

9 August 2017

1 reference